AGP Picks
View all

Press Releases

Stay up to date with press releases covering announcements, company news, product launches, and business updates.

Publish your press release
fallback image
Jul. 27, 2026

Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome

GlobeNewswire, Inc.

fallback image
Jul. 30, 2026

Employment and Labour hosts Hospitality Sector Workshop in Gauteng, 31 Jul

South African Government

fallback image
Jul. 30, 2026

MedVirtual: Front-Office Friction Is Stalling Growth for Independent Medspas and Aesthetic Clinics

GlobeNewswire, Inc.

fallback image
Jul. 30, 2026

ERAS 11-DAY DEADLINE ALERT: HBSS Investigating Pending Claims Against Erasca (ERAS) in Securities Class Action Arising from Patent Litigation and Patient Safety Risks

GlobeNewswire, Inc.

fallback image
Jul. 24, 2026

MJH Life Sciences® Named a 2026 Top Workplace, Reinforcing Its Position as the Leading Health Care Engagement Network for Talented Associates

GlobeNewswire, Inc.

fallback image
Jul. 30, 2026

Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics

GlobeNewswire, Inc.

fallback image
Jul. 30, 2026

Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint

GlobeNewswire, Inc.

fallback image
Jul. 30, 2026

Applied Biologics Announces Successful GMP Manufacturing of Initial Clinical Lots of BIOxHEAL™

GlobeNewswire, Inc.

fallback image
Jul. 30, 2026

How Wisconsin Helped Doogooda Turn Decision Science into Better Healthcare

Wisconsin Economic Development Corporation

fallback image
Jul. 30, 2026

Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

GlobeNewswire, Inc.

fallback image
Jul. 30, 2026

“Hail and Farewell” Celebrates Incoming and Outgoing Fellows at Steadman Philippon Research Institute and The Steadman Clinic

GlobeNewswire, Inc.

fallback image
Jul. 30, 2026

Peripheral Artery Disease Clinical Trial Pipeline Expands as 17+ Companies Race to Redefine Peripheral Artery Disease Treatment Landscape | DelveInsight

GlobeNewswire, Inc.

fallback image
Jul. 30, 2026

On the 61st Anniversary of Medicare and Medicaid, Maryland Democrats are Holding Republicans Accountable for Ripping Away Healthcare From Families

Maryland Democratic Party

fallback image
Jul. 30, 2026

Newly FDA-Approved REVTORPYK™ (gedatolisib) Included in the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines for HR+/HER2- Locally Advanced or Metastatic Breast Cancer

GlobeNewswire, Inc.

fallback image
Jul. 30, 2026

Clearmind Announces Positive Safety Findings for CMND 100, Demonstrating Consistent Tolerability Throughout Full Dose Escalation in Part A of its FDA-Regulated Clinical Trial

GlobeNewswire, Inc.

fallback image
Jul. 30, 2026

Following Recent FDA Advisory Discussions, PepMD Reaffirms Commitment to Clinical Standards and Research

EIN Presswire

fallback image
Jul. 30, 2026

Xtract One Technologies Expands California Healthcare Footprint With Multiple Deployments Across the State

GlobeNewswire, Inc.

fallback image
Jul. 30, 2026

Aprea Therapeutics Provides ACESOT-1051 Program Update for WEE1 Inhibitor APR-1051: Accelerating and Expanding Enrollment. Clinical Data Presentation Planned for Q4 2026

GlobeNewswire, Inc.

fallback image
8 hours ago

Trump’s “Golden Fleet” Could Cost Taxpayers More Than $455 Billion

U.S. Senate Committee on the Budget

fallback image
Aug. 5, 2026

Team effort brings critical support to help a blind Veteran in crisis

U.S. Department of Veterans Affairs

Sign up for:

Healthcare Online Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by: